WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

WXIBF

$6.01

Updated: 24/09/2026, 03:39:51

Market Cap
$24.90B
Sector
Healthcare
Industry
Biotechnology
Country
CN
Stock valuation chart
One-year closing share-price history for WXIBF
Company Profile

WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitates international sales contracting, develops and performs advanced testing services, and manages sales and marketing initiatives. Furthermore, it provides clinical and manufacturing support for biologics, manufactures and distributes medical products, serves as a contract development and manufacturing organization (CDMO) for vaccines, and functions as a material supplier. WuXi Biologics maintains significant strategic collaborations with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc. The organization, founded in 2014, is headquartered in Wuxi, China.

USD
OTC
CEO: Zhisheng Chen
Employees: 13,252
https://www.wuxibiologics.com
Asset Summaries
Latest generated summaries for WXIBF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for WXIBF.
Share price
$6.01
Market cap
$24.90B
Exchange
OTC
Currency
USD
CEO
Zhisheng Chen
Employees
13,252
IPO date
30/01/2018
Beta
0.598
Last dividend
$0.00
Day range
$6.01 – $6.45
52-week range
$3.90 – $6.45
1-day performance
0.00%
1-year performance
54.10%
Current drawdown (1Y)
-6.82%
CIK
N/A
CUSIP
G97008117
ISIN
KYG970081173
Created
07/12/2025, 15:08:48
Last update
24/09/2026, 03:39:51

Track WuXi Biologics (Cayman) Inc. with an AI analyst

See which prediction-market events move WXIBF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to WXIBF from your Railway `news_articles` table.

No news found for this symbol.